Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today ...

Scientists and physicians should advocate to protect the vaccine research infrastructure that has saved an estimated 154 ...

In a new study published in Nature Immunology, researchers at Boston Children's Hospital demonstrated that pairing the ...

In a new study published in Nature Immunology, researchers at Boston Children's Hospital demonstrated that pairing the ...

It's a sign that the agency may be increasing transparency into its decision-making after several controversies.

The Federal Drug Administration has called for a public meeting of independent scientific and public-health experts to review Moderna's experimental influenza vaccine, Mflusiva. A notice released ...

The U.S. FDA said on Thursday it would hold a meeting of outside experts next ​month to review Moderna's experimental flu shot.

In a new interview, Medtronic CEO Geoff Martha — whose company produces high tech medical devices — described the latest in ...

NPR's Scott Detrow talks with virologist Dr. Thomas Geisbert about the vaccine used in the Ebola outbreak of 2014 and the challenges for developing a vaccine for this current health emergency.

Ebola virus is in the headlines again this week. It’s a perennial pathogen, highly contagious and extremely deadly, and its ...

May2026– 4basebio plc (AIM: 4BB), a company pioneering an enzymatically-produced DNA technology serving the next generation ...

The rapid clinical validation of mRNA technology during the COVID‑19 pandemic has powerfully accelerated its application in ...